Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China · Delayed Price · Currency is CNY 11.00
-0.47 (-4.10%)
Apr 29, 2026, 3:04 PM CST
SHE:300485 Revenue
In the year 2025, Beijing Science Sun Pharmaceutical had annual revenue of 404.72M CNY, down -2.82%. Beijing Science Sun Pharmaceutical had revenue of 96.09M in the quarter ending December 31, 2025, with 2.66% growth.
Revenue
404.72M
Revenue Growth
-2.82%
P/S Ratio
13.09
Revenue / Employee
827.65K
Employees
489
Market Cap
5.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 404.72M | -11.76M | -2.82% |
| Dec 31, 2024 | 416.48M | -60.09M | -12.61% |
| Dec 31, 2023 | 476.57M | -257.98M | -35.12% |
| Jan 1, 2023 | 734.55M | -316.26M | -30.10% |
| Jan 1, 2022 | 1.05B | -43.42M | -3.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Bide Pharmatech | 1.32B |
| Beijing Beilu Pharmaceutical | 1.21B |
| Jiangsu Jibeier Pharmaceutical | 990.68M |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |